BlackRock
MDWD icon

BlackRock’s MediWound MDWD Stock Holding History

BlackRock’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.73M Buy
525,929
+80,095
+18% +$1.27M ﹤0.01% 3784
2026
Q1 		$7.18M Sell
445,834
-9,917
-2% -$173K ﹤0.01% 3687
2025
Q4 		$8.41M Buy
455,751
+51,748
+13% +$946K ﹤0.01% 3572
2025
Q3 		$7.28M Sell
404,003
-26,629
-6% -$491K ﹤0.01% 3613
2025
Q2 		$8.34M Sell
430,632
-43,645
-9% -$822K ﹤0.01% 3502
2025
Q1 		$7.36M Buy
474,277
+37,723
+9% +$675K ﹤0.01% 3470
2024
Q4 		$7.77M Buy
436,554
+3,558
+0.8% +$61.3K ﹤0.01% 3546
2024
Q3 		$7.82M Buy
432,996
+44,470
+11% +$812K ﹤0.01% 3529
2024
Q2 		$6.03M Buy
388,526
+374,525
+2,675% +$6.19M ﹤0.01% 3626
2024
Q1 		$200K Buy
14,001
+2,559
+22% +$35K ﹤0.01% 4579
2023
Q4 		$116K Sell
11,442
-3,229
-22% -$29K ﹤0.01% 4771
2023
Q3 		$156K Sell
14,671
-567
-4% -$5.21K ﹤0.01% 4740
2023
Q2 		$162K Buy
15,238
+8,392
+123% +$90.5K ﹤0.01% 4786
2023
Q1 		$91.2K Buy
6,846
+225
+3% +$2.84K ﹤0.01% 4977
2022
Q4 		$89.3K Buy
6,621
+146
+2% +$1.48K ﹤0.01% 5078
2022
Q3 		$63K Sell
6,475
-186
-3% -$2.35K ﹤0.01% 5304
2022
Q2 		$86K Buy
6,661
+584
+10% +$7.73K ﹤0.01% 5275
2022
Q1 		$85K Sell
6,077
-297
-5% -$4.81K ﹤0.01% 5317
2021
Q4 		$106K Buy
6,374
+165
+3% +$3.43K ﹤0.01% 5255
2021
Q3 		$145K Sell
6,209
-132
-2% -$3.52K ﹤0.01% 5054
2021
Q2 		$170K Buy
6,341
+6,022
+1,888% +$186K ﹤0.01% 4931
2021
Q1 		$12K Sell
319
-1,066
-77% -$38.6K ﹤0.01% 5071
2020
Q4 		$36K Sell
1,385
-1,306
-49% -$33.9K ﹤0.01% 4707
2020
Q3 		$71K Sell
2,691
-1,116
-29% -$28.5K ﹤0.01% 4563
2020
Q2 		$79K Buy
3,807
+476
+14% +$6.78K ﹤0.01% 4523
2020
Q1 		$37K Hold
3,331
– – ﹤0.01% 4528
2019
Q4 		$72K Buy
+3,331
New +$69.1K ﹤0.01% 4493

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

BlackRock's MDWD Position: Q2 2026 in Review

BlackRock increased its MediWound (MDWD) stake by 18% in Q2 2026, buying an estimated $1.27M and bringing the position to 525,929 shares worth $7.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3784.

BlackRock first reported a position in MDWD in Q4 2019 and has held it in 27 quarters since. The position peaked at $8.41M in Q4 2025. 78 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • BlackRock held 525,929 shares of MediWound worth $7.73M as of Q2 2026.
  • BlackRock bought 80,095 MediWound shares in Q2 2026, an estimated $1.27M.
  • MediWound made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3784 holding.
  • BlackRock first reported a position in MediWound in Q4 2019 and has held it in 27 quarters since.
  • BlackRock's MediWound position peaked at $8.41M in Q4 2025.
  • 78 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.